United Kingdom
As an MBPhD student at UCL, I am exploring the field of drug development and complement protein biology, with a particular focus on renal complement proteins. My research involves designing and performing biochemical and biophysical experiments to identify potential therapeutic modulators, while also leading data analysis and interpretation, integrating both experimental and computational results to support and refine hypotheses. Working closely with interdisciplinary teams of chemists, biologists, and clinicians, I contribute to projects aimed at advancing translational applications in therapeutic development. A major success to date has been the execution of high-throughput molecular docking, which identified promising candidate molecules poised to drive forward drug discovery efforts.
In my role as Financial Coordinator for the International Undergraduate Surgical Conference, I was entrusted with the critical responsibility of overseeing and managing the financial operations for one of the most anticipated events in the academic surgical community. This position required a meticulous approach to budget planning, financial management, and resource allocation to ensure the seamless execution of a conference that welcomed aspiring surgeons, esteemed professionals, and industry leaders from around the globe.
In a defining moment of my early career, I had the honor of presenting my research on Hemophilia B at a prestigious conference hosted by the Lister Institute for Preventive Medicine. This opportunity allowed me to showcase the findings of my published paper on Factor IX, which offers a comprehensive analysis of 1692 genetic variants related to this condition.
My summer research internship was an enlightening journey into the genetic landscapes of haemophilia A, where I dedicated my efforts to uncovering new genetic mutations responsible for this condition. Tasked with a pivotal role, I was instrumental in identifying these mutations and meticulously compiling them into a comprehensive mySQL database, specifically designed to enhance our understanding and treatment of haemophilia A.
As a dedicated summer research student passionate about advancing the field of genetic research in coagulation disorders, I had the privilege of contributing to a significant advancement in the study of hemophilia B. In 2023, I co-authored and published a pivotal paper titled, "An updated interactive database for 1692 genetic variants in coagulation factor IX provides detailed insights into hemophilia B." This work introduces a comprehensive, user-friendly database designed to facilitate the exploration and understanding of the genetic complexities underlying hemophilia B.